Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: Main findings and clinical follow-up of a large multicenter randomized clinical trial in β-thalassemia major patients

Hemoglobin

Volumn 35, Issue 3, 2011, Pages 206-216

  Pantalone, Gaetano Restivo ^a   Maggio, Aurelio ^a   Vitrano, Angela ^a   Capra, Marcello ^b   Cuccia, Liana ^b   Gagliardotto, Francesco ^b   Filosa, Aldo ^c   Romeo, Maria Antonietta ^d   Magnano, Carmelo ^e   Caruso, Vincenzo ^e   Argento, Crocetta ^f   Gerardi, Calogera ^g   Campisi, Saveria ^h   Violi, Pietro ⁱ   Malizia, Roberto ^a   Cianciulli, Paolo ^j   Rizzo, Michele ^k   D''ascola, Domenico Giuseppe ^l   Quota, Alessandra ^m   Prossomariti, Luciano ^c   Fidone, Carmelo ⁿ   Rigano, Paolo ^a   Pepe, Alessia ^o   D'amico, Gennaro ^a   Morabito, Alberto ^p   Gluud, Christian ^q   more..

^a Azienda Ospedaliera Villa Sofia   (Italy)

^b Centro di Prevenzione Diagnosi e Cura della Talassemia   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e Azienda Ospedaliera Garibaldi   (Italy)

^f Azienda Ospedaliera San Giovanni di Dio   (Italy)

^g Presidio Ospedaliero Giovanni Pauloo II   (Italy)

^h Osp Umberto I   (Italy)

ⁱ CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^j Azienda Ospedaliera   (Italy)

^k Azienda Ospedaliera S Elia   (Italy)

^l BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^m Osp Vittorio Emanuele III   (Italy)

ⁿ Azienda Ospedaliera Civile Maria Paterno Arezzo   (Italy)

^o CNR   (Italy)

^p UNIVERSITY OF MILAN   (Italy)

^q Mental Health Services CPH   (Denmark)

more..

Author keywords

Deferiprone (L1); Deferroxamine (DFO); Iron chelation therapy; Iron overload; Thalassemia

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; FERRITIN; IRON; PROTHROMBIN; TRANSFERRIN; ZINC;

ADULT; AGRANULOCYTOSIS; ARTHRALGIA; BLOOD TRANSFUSION; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NEUTROPENIA; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SURVIVAL; THALASSEMIA MAJOR; TREATMENT DURATION;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHELATION THERAPY; DEFEROXAMINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRON CHELATING AGENTS; MALE; PYRIDONES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79957483630     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2011.570674     Document Type: Conference Paper

References (12)

1. Porter JB, Shan FT. Iron overload in thalassemia and related conditions: therapeutic goals and assessment of response to chelation therapies. Hematol/Oncol Clin North Am. 2010;24(6): 1109-1130
2. Kolnagou A, Kontoghiorges GJ. New golden era of chelation therapy in thalassaemia: the achievement and maintenance of normal range body iron. Br J Haematol. 2010;150(4): 489-490
3. Maggio A. Light and shadows in the iron chelation treatment of haematological diseases. Br J Haematol. 2007;138(4): 407-21 (Pubitemid 47063024)
4. Farmaki K, Tzoumari I, Pappa C, et al. Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major. Br J Haematol. 2010;148(3): 466-475
5. Galanello R, Kattamis A, Piga A, et al. A prospective randomised controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia. Haematologica. 2006;91(9): 1241-1243 (Pubitemid 44408435)
6. Maggio A, Vitrano A, Capra M, et al. Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomised clinical trial. Br J Haematol. 2009;145(2): 245-254
7. Wood JC, Noetzli L. Cardiovascular MRI in thalassemiamajor. Ann NY Acad Sci. 2010;1202: 173-179
8. Meloni A, Positano V, Pepe A, et al. Preferential patterns of myocardial iron overload by multislice multiecho T*2 CMR in thalassemia major patients. Magn Reson Med. 2010;64(1): 211-219
9. Pepe A, Meloni A, Capra M, et al. Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging. Haematologica. 2011;96(1): 41-47
10. Hedeker D, Gibbons RD. Longitudinal Data Analysis. Hoboken: Wiley-Interscience. 2006
11. Galanello R, Campus S. Deferiprone chelation therapy for thalassemia major. Acta Haematol. 2009;122(2-3): 155-164
12. Pontikoglou C, Papadaki HA. Idiosyncratic drug-induced agranulocytosis: the paradigm of deferiprone. Hemoglobin. 2010; 34(3): 291-304